Coherus Oncology (CHRS) EBIT Margin (QoQ) (2013 - 2026)
Coherus Oncology (CHRS) EBIT Margin (QoQ) (2013 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 137.11 Bn | 129.26 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 84.98 Bn | 76.99 Bn | 3.93 Bn |
| 3 | Argenx Se | 64.52 Bn | 59.33 Bn | 1.37 Bn |
| 4 | Moderna | 53.23 Bn | 48.09 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 41.23 Bn | 36.14 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 30.65 Bn | 27.34 Bn | 992.69 Mn |
| 7 | Insmed | 27.15 Bn | 25.99 Bn | 358.27 Mn |
| 8 | Royalty Pharma | 26.98 Bn | 26.14 Bn | - |
| 9 | BioNTech SE | 26.78 Bn | 8.39 Bn | 668.28 Mn |
| 10 | Coherus Oncology | 203.82 Mn | 98.51 Mn | 10.07 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 6,769.00 |
| Mar 31, 2026 | 6,623.00 |
| Dec 31, 2025 | 2,324.00 |
| Sep 30, 2025 | 6,045.00 |
| Jun 30, 2025 | 15,431.00 |
| Mar 31, 2025 | -1,102.00 |
| Dec 31, 2024 | 18,734.00 |
| Sep 30, 2024 | -38,936.00 |
| Jun 30, 2024 | 255,218.00 |
| Mar 31, 2024 | -286,176.00 |
| Dec 31, 2023 | -3,236.00 |
| Sep 30, 2023 | 1,591.00 |
| Jun 30, 2023 | 15,003.00 |
| Mar 31, 2023 | -9,532.00 |
| Dec 31, 2022 | 6,357.00 |
| Sep 30, 2022 | -10,394.00 |
| Jun 30, 2022 | 6,145.00 |
| Mar 31, 2022 | -8,070.00 |
| Dec 31, 2021 | -1,417.00 |
| Sep 30, 2021 | -1,217.00 |